Unexpected proatherogenic properties of p21: beyond cell cycle control?
Andrés
Vicente
V
D000818:Animals; D001018:Aortic Diseases / Q000201:enzymology / Q000209:etiology / Q000235:genetics; D001057:Apolipoproteins E / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D001161:Arteriosclerosis / Q000201:enzymology* / Q000209:etiology / Q000235:genetics; D016026:Bone Marrow Transplantation; D002453:Cell Cycle / Q000502:physiology; D018797:Cell Cycle Proteins / Q000037:antagonists & inhibitors / Q000502:physiology*; D002455:Cell Division; D050759:Cyclin-Dependent Kinase Inhibitor p21; D050760:Cyclin-Dependent Kinase Inhibitor p27; D050761:Cyclin-Dependent Kinase Inhibitor p57; D004036:Diet, Atherogenic; D004195:Disease Models, Animal; D016158:Genes, p53; D006801:Humans; D006965:Hyperplasia; D051379:Mice; D018345:Mice, Knockout; D009687:Nuclear Proteins / Q000502:physiology; D016376:Oligonucleotides, Antisense / Q000494:pharmacology; D011973:Receptors, LDL / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D013234:Stem Cells / Q000166:cytology / Q000201:enzymology; D025521:Tumor Suppressor Proteins / Q000502:physiology; D017539:Tunica Intima / Q000473:pathology
D001057:Apolipoproteins E; C493956:CDKN1A protein, human; C493964:CDKN1C protein, human; C493957:Cdkn1a protein, mouse; C493961:Cdkn1b protein, mouse; C493965:Cdkn1c protein, mouse; D018797:Cell Cycle Proteins; D050759:Cyclin-Dependent Kinase Inhibitor p21; D050761:Cyclin-Dependent Kinase Inhibitor p57; D009687:Nuclear Proteins; D016376:Oligonucleotides, Antisense; D011973:Receptors, LDL; D025521:Tumor Suppressor Proteins; D050760:Cyclin-Dependent Kinase Inhibitor p27